Paid Clinical Trials Concord

Discover 301 paid clinical trials in Concord, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 301

EmicizumabReal World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Recruiting

Sponsor:

Montefiore Medical Center

Location:

Lebanon NH, Hartford CT, New Haven CT, Bronx NYshow 6 more

Code:

NCT05248594

Conditions

Hemophilia A

Eligibility Criteria

Sex: All

Age: 0 - 36

Healthy Volunteers: Not accepted

Interventions

HEMLIBRA

Serplulimab & ChemotherapyTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Lebanon NH, Burlington MA, Boston MA, Providence RIshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Chemotherapy & ImmunotherapyChemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Londonderry NH, Methuen MA, Lebanon NH, Boston MAshow 226 more

Code:

NCT06096844

Conditions

Advanced Lung Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IIIC Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 70+

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Computed Tomography

Magnetic Resonance Imaging

Nab-paclitaxel

Paclitaxel

Observational StudyStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Recruiting

Sponsor:

Dana-Farber Cancer Institute

Location:

Londonderry NH, Methuen MA, Brighton MA, Boston MAshow 3 more

Code:

NCT02269592

Conditions

Monoclonal Gammopathy of Undetermined Significance (MGUS)

Chronic Lymphocytic Leukemia (CLL)

Myelodysplastic Syndromes

Hematological Malignancies

B-cell Malignancy, Low-grade

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

CrizotinibCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Concord NH, Manchester NH, Laconia NH, Derry NHshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis

EltrekibartA Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Portsmouth NH, Boston MA, Farmington CT, Quebec Cityshow 40 more

Code:

NCT06046729

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Eltrekibart

Placebo

Zenith® Fenestrated+Zenith® Fenestrated+ Clinical Study

Recruiting

Sponsor:

Cook Research Incorporated

Location:

Lebanon NH, Boston MA, Worcester MA, New York NYshow 24 more

Code:

NCT04875429

Conditions

Aortic Aneurysm, Abdominal

Juxtarenal Aortic Aneurysm

Extent IV Thoracoabdominal

Pararenal Aneurysm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zenith Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System and Unibody2

Observational StudyOCT in Open Fracture and Infected Fracture

Recruiting

Sponsor:

Dartmouth-Hitchcock Medical Center

Location:

Lebanon NH

Code:

NCT05785182

Conditions

Trauma Injury

Trauma

Open Fracture

Fracture Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Open Fracture

Infected Fracture

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Burlington MA, Boston MA, Foxboro MA, Bronx NYshow 62 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

MILDMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Concord OH, Manchester NH, Bedford NH, Nashua NHshow 1096 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression